BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210316T160000
DTEND;TZID=America/Vancouver:20210316T170000
DTSTAMP:20260404T183518
CREATED:20210226T192204Z
LAST-MODIFIED:20210226T192204Z
UID:15197-1615910400-1615914000@scienceinvancouver.com
SUMMARY:Annual Distinguished Neuroethics Lecture: Hacking the Mind
DESCRIPTION:As it advances\, our relationship with brain technology will change. In this lecture\, Dr. Nir Lipsman will discuss how our knowledge of brain circuitry\, and how it can go wrong\, has informed our understanding of human behaviour. We will then discuss the implications of more sophisticated\, precise and less intrusive brain technology\, on that relationship\, and what it could all mean for the next generation of brain therapy and beyond… \nNir Lipsman MD\, PhD\, FRCSC \nDr. Nir Lipsman is a neurosurgeon and scientist at Sunnybrook Health Sciences Centre and an Assistant Professor of Surgery at the University of Toronto. He completed his undergraduate degree at the University of Toronto followed by a medical degree at Queen’s University\, and a neurosurgical residency at the University of Toronto. During his residency\, Dr. Lipsman completed his PhD investigating novel neuromodulation strategies in patients with treatment-resistant psychiatric and neurologic conditions. He is currently the Director of Sunnybrook’s Harquail Center for Neuromodulation\, and the Clinical Director of Sunnybrook’s Focused Ultrasound Centre of Excellence. \nDr. Lipsman has helped develop several clinical trials of MR-guided focused ultrasound (FUS) in novel indications\, including among the world’s first experience of FUS in essential tremor\, obsessive-compulsive disorder\, major depression and chronic pain\, as well as the first randomized control trial of FUS in tremor. He has led the world’s first application of FUS-mediated blood brain barrier (BBB) opening in Alzheimer’s Disease\, and helped develop the first applications in primary and secondary brain tumors and ALS. He has published over 100 peer-reviewed papers and book chapters\, including in The Lancet\, Lancet Neurology\, Lancet Psychiatry\, New England Journal of Medicine\, and Neuron. \nDr. Lipsman also has a strong interest in the broader clinical and ethical implications of neuromodulation\, and has been closely involved in the development of international guidelines for the use of surgery in psychiatric disease. In collaboration with Drs. Judy Illes and Pat McDonald at UBC\, he helped found the Pan Canadian Neurotechnology Ethics Consortium (PCNEC)\, bringing together experts in neuromodulation and ethics\, to identify and tackle the most pressing ethical questions in the field. \nThis event will be held via Zoom. A link to the talk will be distributed by email to the attendees prior to the event.
URL:https://scienceinvancouver.com/event/annual-distinguished-neuroethics-lecture-hacking-the-mind-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/02/Hacking-the-Mind.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210316T160000
DTEND;TZID=America/Vancouver:20210316T170000
DTSTAMP:20260404T183518
CREATED:20210226T192204Z
LAST-MODIFIED:20210226T192204Z
UID:26349-1615910400-1615914000@scienceinvancouver.com
SUMMARY:Annual Distinguished Neuroethics Lecture: Hacking the Mind
DESCRIPTION:As it advances\, our relationship with brain technology will change. In this lecture\, Dr. Nir Lipsman will discuss how our knowledge of brain circuitry\, and how it can go wrong\, has informed our understanding of human behaviour. We will then discuss the implications of more sophisticated\, precise and less intrusive brain technology\, on that relationship\, and what it could all mean for the next generation of brain therapy and beyond… \nNir Lipsman MD\, PhD\, FRCSC \nDr. Nir Lipsman is a neurosurgeon and scientist at Sunnybrook Health Sciences Centre and an Assistant Professor of Surgery at the University of Toronto. He completed his undergraduate degree at the University of Toronto followed by a medical degree at Queen’s University\, and a neurosurgical residency at the University of Toronto. During his residency\, Dr. Lipsman completed his PhD investigating novel neuromodulation strategies in patients with treatment-resistant psychiatric and neurologic conditions. He is currently the Director of Sunnybrook’s Harquail Center for Neuromodulation\, and the Clinical Director of Sunnybrook’s Focused Ultrasound Centre of Excellence. \nDr. Lipsman has helped develop several clinical trials of MR-guided focused ultrasound (FUS) in novel indications\, including among the world’s first experience of FUS in essential tremor\, obsessive-compulsive disorder\, major depression and chronic pain\, as well as the first randomized control trial of FUS in tremor. He has led the world’s first application of FUS-mediated blood brain barrier (BBB) opening in Alzheimer’s Disease\, and helped develop the first applications in primary and secondary brain tumors and ALS. He has published over 100 peer-reviewed papers and book chapters\, including in The Lancet\, Lancet Neurology\, Lancet Psychiatry\, New England Journal of Medicine\, and Neuron. \nDr. Lipsman also has a strong interest in the broader clinical and ethical implications of neuromodulation\, and has been closely involved in the development of international guidelines for the use of surgery in psychiatric disease. In collaboration with Drs. Judy Illes and Pat McDonald at UBC\, he helped found the Pan Canadian Neurotechnology Ethics Consortium (PCNEC)\, bringing together experts in neuromodulation and ethics\, to identify and tackle the most pressing ethical questions in the field. \nThis event will be held via Zoom. A link to the talk will be distributed by email to the attendees prior to the event.
URL:https://scienceinvancouver.com/event/annual-distinguished-neuroethics-lecture-hacking-the-mind-2-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/02/Hacking-the-Mind.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210316T160000
DTEND;TZID=America/Vancouver:20210316T170000
DTSTAMP:20260404T183518
CREATED:20210226T192204Z
LAST-MODIFIED:20210226T192204Z
UID:27964-1615910400-1615914000@scienceinvancouver.com
SUMMARY:Annual Distinguished Neuroethics Lecture: Hacking the Mind
DESCRIPTION:As it advances\, our relationship with brain technology will change. In this lecture\, Dr. Nir Lipsman will discuss how our knowledge of brain circuitry\, and how it can go wrong\, has informed our understanding of human behaviour. We will then discuss the implications of more sophisticated\, precise and less intrusive brain technology\, on that relationship\, and what it could all mean for the next generation of brain therapy and beyond… \nNir Lipsman MD\, PhD\, FRCSC \nDr. Nir Lipsman is a neurosurgeon and scientist at Sunnybrook Health Sciences Centre and an Assistant Professor of Surgery at the University of Toronto. He completed his undergraduate degree at the University of Toronto followed by a medical degree at Queen’s University\, and a neurosurgical residency at the University of Toronto. During his residency\, Dr. Lipsman completed his PhD investigating novel neuromodulation strategies in patients with treatment-resistant psychiatric and neurologic conditions. He is currently the Director of Sunnybrook’s Harquail Center for Neuromodulation\, and the Clinical Director of Sunnybrook’s Focused Ultrasound Centre of Excellence. \nDr. Lipsman has helped develop several clinical trials of MR-guided focused ultrasound (FUS) in novel indications\, including among the world’s first experience of FUS in essential tremor\, obsessive-compulsive disorder\, major depression and chronic pain\, as well as the first randomized control trial of FUS in tremor. He has led the world’s first application of FUS-mediated blood brain barrier (BBB) opening in Alzheimer’s Disease\, and helped develop the first applications in primary and secondary brain tumors and ALS. He has published over 100 peer-reviewed papers and book chapters\, including in The Lancet\, Lancet Neurology\, Lancet Psychiatry\, New England Journal of Medicine\, and Neuron. \nDr. Lipsman also has a strong interest in the broader clinical and ethical implications of neuromodulation\, and has been closely involved in the development of international guidelines for the use of surgery in psychiatric disease. In collaboration with Drs. Judy Illes and Pat McDonald at UBC\, he helped found the Pan Canadian Neurotechnology Ethics Consortium (PCNEC)\, bringing together experts in neuromodulation and ethics\, to identify and tackle the most pressing ethical questions in the field. \nThis event will be held via Zoom. A link to the talk will be distributed by email to the attendees prior to the event.
URL:https://scienceinvancouver.com/event/annual-distinguished-neuroethics-lecture-hacking-the-mind-2-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/02/Hacking-the-Mind.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210316T160000
DTEND;TZID=America/Vancouver:20210316T170000
DTSTAMP:20260404T183518
CREATED:20210226T192204Z
LAST-MODIFIED:20210226T192204Z
UID:31047-1615910400-1615914000@scienceinvancouver.com
SUMMARY:Annual Distinguished Neuroethics Lecture: Hacking the Mind
DESCRIPTION:As it advances\, our relationship with brain technology will change. In this lecture\, Dr. Nir Lipsman will discuss how our knowledge of brain circuitry\, and how it can go wrong\, has informed our understanding of human behaviour. We will then discuss the implications of more sophisticated\, precise and less intrusive brain technology\, on that relationship\, and what it could all mean for the next generation of brain therapy and beyond… \nNir Lipsman MD\, PhD\, FRCSC \nDr. Nir Lipsman is a neurosurgeon and scientist at Sunnybrook Health Sciences Centre and an Assistant Professor of Surgery at the University of Toronto. He completed his undergraduate degree at the University of Toronto followed by a medical degree at Queen’s University\, and a neurosurgical residency at the University of Toronto. During his residency\, Dr. Lipsman completed his PhD investigating novel neuromodulation strategies in patients with treatment-resistant psychiatric and neurologic conditions. He is currently the Director of Sunnybrook’s Harquail Center for Neuromodulation\, and the Clinical Director of Sunnybrook’s Focused Ultrasound Centre of Excellence. \nDr. Lipsman has helped develop several clinical trials of MR-guided focused ultrasound (FUS) in novel indications\, including among the world’s first experience of FUS in essential tremor\, obsessive-compulsive disorder\, major depression and chronic pain\, as well as the first randomized control trial of FUS in tremor. He has led the world’s first application of FUS-mediated blood brain barrier (BBB) opening in Alzheimer’s Disease\, and helped develop the first applications in primary and secondary brain tumors and ALS. He has published over 100 peer-reviewed papers and book chapters\, including in The Lancet\, Lancet Neurology\, Lancet Psychiatry\, New England Journal of Medicine\, and Neuron. \nDr. Lipsman also has a strong interest in the broader clinical and ethical implications of neuromodulation\, and has been closely involved in the development of international guidelines for the use of surgery in psychiatric disease. In collaboration with Drs. Judy Illes and Pat McDonald at UBC\, he helped found the Pan Canadian Neurotechnology Ethics Consortium (PCNEC)\, bringing together experts in neuromodulation and ethics\, to identify and tackle the most pressing ethical questions in the field. \nThis event will be held via Zoom. A link to the talk will be distributed by email to the attendees prior to the event.
URL:https://scienceinvancouver.com/event/annual-distinguished-neuroethics-lecture-hacking-the-mind-2-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/02/Hacking-the-Mind.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210316T160000
DTEND;TZID=America/Vancouver:20210316T170000
DTSTAMP:20260404T183518
CREATED:20210226T192204Z
LAST-MODIFIED:20210226T192204Z
UID:32507-1615910400-1615914000@scienceinvancouver.com
SUMMARY:Annual Distinguished Neuroethics Lecture: Hacking the Mind
DESCRIPTION:As it advances\, our relationship with brain technology will change. In this lecture\, Dr. Nir Lipsman will discuss how our knowledge of brain circuitry\, and how it can go wrong\, has informed our understanding of human behaviour. We will then discuss the implications of more sophisticated\, precise and less intrusive brain technology\, on that relationship\, and what it could all mean for the next generation of brain therapy and beyond… \nNir Lipsman MD\, PhD\, FRCSC \nDr. Nir Lipsman is a neurosurgeon and scientist at Sunnybrook Health Sciences Centre and an Assistant Professor of Surgery at the University of Toronto. He completed his undergraduate degree at the University of Toronto followed by a medical degree at Queen’s University\, and a neurosurgical residency at the University of Toronto. During his residency\, Dr. Lipsman completed his PhD investigating novel neuromodulation strategies in patients with treatment-resistant psychiatric and neurologic conditions. He is currently the Director of Sunnybrook’s Harquail Center for Neuromodulation\, and the Clinical Director of Sunnybrook’s Focused Ultrasound Centre of Excellence. \nDr. Lipsman has helped develop several clinical trials of MR-guided focused ultrasound (FUS) in novel indications\, including among the world’s first experience of FUS in essential tremor\, obsessive-compulsive disorder\, major depression and chronic pain\, as well as the first randomized control trial of FUS in tremor. He has led the world’s first application of FUS-mediated blood brain barrier (BBB) opening in Alzheimer’s Disease\, and helped develop the first applications in primary and secondary brain tumors and ALS. He has published over 100 peer-reviewed papers and book chapters\, including in The Lancet\, Lancet Neurology\, Lancet Psychiatry\, New England Journal of Medicine\, and Neuron. \nDr. Lipsman also has a strong interest in the broader clinical and ethical implications of neuromodulation\, and has been closely involved in the development of international guidelines for the use of surgery in psychiatric disease. In collaboration with Drs. Judy Illes and Pat McDonald at UBC\, he helped found the Pan Canadian Neurotechnology Ethics Consortium (PCNEC)\, bringing together experts in neuromodulation and ethics\, to identify and tackle the most pressing ethical questions in the field. \nThis event will be held via Zoom. A link to the talk will be distributed by email to the attendees prior to the event.
URL:https://scienceinvancouver.com/event/annual-distinguished-neuroethics-lecture-hacking-the-mind-2-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/02/Hacking-the-Mind.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210319T110000
DTEND;TZID=America/Vancouver:20210319T120000
DTSTAMP:20260404T183518
CREATED:20210316T172114Z
LAST-MODIFIED:20210316T172114Z
UID:15624-1616151600-1616155200@scienceinvancouver.com
SUMMARY:LSI Virtual Seminar
DESCRIPTION:How do pH and changes in the environment influence gut microbiota? Drs. Kat Ng and Jen Nguyen share the latest insights on cutting edge work out of Dr. Carolina Tropini’s lab.  \nTropini Lab/Kat Ng: Exploring the effects of pH on the microbiota in health and disease \nJen Nguyen: Environmental fluctuations and their effects on microbial growth and ecology
URL:https://scienceinvancouver.com/event/lsi-virtual-seminar/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/LSI-Virtual-Seminar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210319T110000
DTEND;TZID=America/Vancouver:20210319T120000
DTSTAMP:20260404T183518
CREATED:20210316T172114Z
LAST-MODIFIED:20210316T172114Z
UID:26363-1616151600-1616155200@scienceinvancouver.com
SUMMARY:LSI Virtual Seminar
DESCRIPTION:How do pH and changes in the environment influence gut microbiota? Drs. Kat Ng and Jen Nguyen share the latest insights on cutting edge work out of Dr. Carolina Tropini’s lab.  \nTropini Lab/Kat Ng: Exploring the effects of pH on the microbiota in health and disease \nJen Nguyen: Environmental fluctuations and their effects on microbial growth and ecology
URL:https://scienceinvancouver.com/event/lsi-virtual-seminar-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/LSI-Virtual-Seminar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210319T110000
DTEND;TZID=America/Vancouver:20210319T120000
DTSTAMP:20260404T183519
CREATED:20210316T172114Z
LAST-MODIFIED:20210316T172114Z
UID:27979-1616151600-1616155200@scienceinvancouver.com
SUMMARY:LSI Virtual Seminar
DESCRIPTION:How do pH and changes in the environment influence gut microbiota? Drs. Kat Ng and Jen Nguyen share the latest insights on cutting edge work out of Dr. Carolina Tropini’s lab.  \nTropini Lab/Kat Ng: Exploring the effects of pH on the microbiota in health and disease \nJen Nguyen: Environmental fluctuations and their effects on microbial growth and ecology
URL:https://scienceinvancouver.com/event/lsi-virtual-seminar-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/LSI-Virtual-Seminar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210319T110000
DTEND;TZID=America/Vancouver:20210319T120000
DTSTAMP:20260404T183519
CREATED:20210316T172114Z
LAST-MODIFIED:20210316T172114Z
UID:31062-1616151600-1616155200@scienceinvancouver.com
SUMMARY:LSI Virtual Seminar
DESCRIPTION:How do pH and changes in the environment influence gut microbiota? Drs. Kat Ng and Jen Nguyen share the latest insights on cutting edge work out of Dr. Carolina Tropini’s lab.  \nTropini Lab/Kat Ng: Exploring the effects of pH on the microbiota in health and disease \nJen Nguyen: Environmental fluctuations and their effects on microbial growth and ecology
URL:https://scienceinvancouver.com/event/lsi-virtual-seminar-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/LSI-Virtual-Seminar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210319T110000
DTEND;TZID=America/Vancouver:20210319T120000
DTSTAMP:20260404T183519
CREATED:20210316T172114Z
LAST-MODIFIED:20210316T172114Z
UID:32522-1616151600-1616155200@scienceinvancouver.com
SUMMARY:LSI Virtual Seminar
DESCRIPTION:How do pH and changes in the environment influence gut microbiota? Drs. Kat Ng and Jen Nguyen share the latest insights on cutting edge work out of Dr. Carolina Tropini’s lab.  \nTropini Lab/Kat Ng: Exploring the effects of pH on the microbiota in health and disease \nJen Nguyen: Environmental fluctuations and their effects on microbial growth and ecology
URL:https://scienceinvancouver.com/event/lsi-virtual-seminar-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/LSI-Virtual-Seminar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210329T100000
DTEND;TZID=America/Vancouver:20210331T110000
DTSTAMP:20260404T183519
CREATED:20210312T171957Z
LAST-MODIFIED:20210312T171957Z
UID:15490-1617012000-1617188400@scienceinvancouver.com
SUMMARY:UBC Science Communication Week
DESCRIPTION:Please join the UBC Graduate Student Society and the UBC Faculty of Medicine (FoM) Graduate and Postdoctoral Education Office for a series of Science Communication workshops\, a Twitter Research Conference\, as well as a closing keynote with Dr. Jennifer Gardy from March 29 to 31st\, 2021!
URL:https://scienceinvancouver.com/event/ubc-science-communication-week/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Overall-Cover-Photo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210329T100000
DTEND;TZID=America/Vancouver:20210331T110000
DTSTAMP:20260404T183519
CREATED:20210312T171957Z
LAST-MODIFIED:20210312T171957Z
UID:26356-1617012000-1617188400@scienceinvancouver.com
SUMMARY:UBC Science Communication Week
DESCRIPTION:Please join the UBC Graduate Student Society and the UBC Faculty of Medicine (FoM) Graduate and Postdoctoral Education Office for a series of Science Communication workshops\, a Twitter Research Conference\, as well as a closing keynote with Dr. Jennifer Gardy from March 29 to 31st\, 2021!
URL:https://scienceinvancouver.com/event/ubc-science-communication-week-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Overall-Cover-Photo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210329T100000
DTEND;TZID=America/Vancouver:20210331T110000
DTSTAMP:20260404T183519
CREATED:20210312T171957Z
LAST-MODIFIED:20210312T171957Z
UID:27971-1617012000-1617188400@scienceinvancouver.com
SUMMARY:UBC Science Communication Week
DESCRIPTION:Please join the UBC Graduate Student Society and the UBC Faculty of Medicine (FoM) Graduate and Postdoctoral Education Office for a series of Science Communication workshops\, a Twitter Research Conference\, as well as a closing keynote with Dr. Jennifer Gardy from March 29 to 31st\, 2021!
URL:https://scienceinvancouver.com/event/ubc-science-communication-week-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Overall-Cover-Photo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210329T100000
DTEND;TZID=America/Vancouver:20210331T110000
DTSTAMP:20260404T183519
CREATED:20210312T171957Z
LAST-MODIFIED:20210312T171957Z
UID:31055-1617012000-1617188400@scienceinvancouver.com
SUMMARY:UBC Science Communication Week
DESCRIPTION:Please join the UBC Graduate Student Society and the UBC Faculty of Medicine (FoM) Graduate and Postdoctoral Education Office for a series of Science Communication workshops\, a Twitter Research Conference\, as well as a closing keynote with Dr. Jennifer Gardy from March 29 to 31st\, 2021!
URL:https://scienceinvancouver.com/event/ubc-science-communication-week-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Overall-Cover-Photo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210329T100000
DTEND;TZID=America/Vancouver:20210331T110000
DTSTAMP:20260404T183519
CREATED:20210312T171957Z
LAST-MODIFIED:20210312T171957Z
UID:32515-1617012000-1617188400@scienceinvancouver.com
SUMMARY:UBC Science Communication Week
DESCRIPTION:Please join the UBC Graduate Student Society and the UBC Faculty of Medicine (FoM) Graduate and Postdoctoral Education Office for a series of Science Communication workshops\, a Twitter Research Conference\, as well as a closing keynote with Dr. Jennifer Gardy from March 29 to 31st\, 2021!
URL:https://scienceinvancouver.com/event/ubc-science-communication-week-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Overall-Cover-Photo.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T130000
DTSTAMP:20260404T183519
CREATED:20210315T193355Z
LAST-MODIFIED:20210315T193355Z
UID:15586-1617192000-1617195600@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: The Development of a Risk of Bias Tool for Network Meta-Analysis
DESCRIPTION:The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nTITLE: The development of a risk of bias tool for network meta-analysis \nSPEAKER: Dr. Carole Lunny\, Postdoctoral Research Fellow\, Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, ON. \n\nAbout the topic: In this presentation\, Dr. Lunny will describe tools that are currently used to assess the quality and risk of bias in systematic reviews with or without meta-analysis\, and justify why a new risk of bias tool for NMAs is needed. She will also describe the way to choose a quality assessment tool based on rigorous methodology and describe proposed methods for the development of a risk of bias tool for NMAs. Scroll down to read the abstract for this presentation. \nAbout the speaker: Dr. Carole Lunny is a postdoc research methodologist with the Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, and a Methodology Editor with the Cochrane Hypertension Review Group\, the Therapeutics Initiative at the University of British Columbia. She specializes in methods for research synthesis and critical appraisal of systematic reviews with pairwise and network meta-analysis\, overviews of reviews\, randomised controlled trials\, and observational studies (cohort\, case control). Her current research focuses on the development of a risk of bias tool for network meta-analyses\, methods issues in clinical practice guidelines and ‘overviews of reviews’. Her list of publications can be found at: https://scholar.google.com/citations?user=YaJAbZsAAAAJ&hl=en&oi=ao She completed her PhD training as an epidemiologist in 2018 with Cochrane Australia at Monash University and recently completed a postdoctoral research fellowship with the Therapeutics Initiative (Cochrane Hypertension Group) at the University of British Columbia. She is a member of the several methods groups at Cochrane\, academic board advisor for Researchsquare.com\, and academic editor for PeerJ. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-the-development-of-a-risk-of-bias-tool-for-network-meta-analysis/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T130000
DTSTAMP:20260404T183519
CREATED:20210315T193355Z
LAST-MODIFIED:20210315T193355Z
UID:26362-1617192000-1617195600@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: The Development of a Risk of Bias Tool for Network Meta-Analysis
DESCRIPTION:The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nTITLE: The development of a risk of bias tool for network meta-analysis \nSPEAKER: Dr. Carole Lunny\, Postdoctoral Research Fellow\, Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, ON. \n\nAbout the topic: In this presentation\, Dr. Lunny will describe tools that are currently used to assess the quality and risk of bias in systematic reviews with or without meta-analysis\, and justify why a new risk of bias tool for NMAs is needed. She will also describe the way to choose a quality assessment tool based on rigorous methodology and describe proposed methods for the development of a risk of bias tool for NMAs. Scroll down to read the abstract for this presentation. \nAbout the speaker: Dr. Carole Lunny is a postdoc research methodologist with the Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, and a Methodology Editor with the Cochrane Hypertension Review Group\, the Therapeutics Initiative at the University of British Columbia. She specializes in methods for research synthesis and critical appraisal of systematic reviews with pairwise and network meta-analysis\, overviews of reviews\, randomised controlled trials\, and observational studies (cohort\, case control). Her current research focuses on the development of a risk of bias tool for network meta-analyses\, methods issues in clinical practice guidelines and ‘overviews of reviews’. Her list of publications can be found at: https://scholar.google.com/citations?user=YaJAbZsAAAAJ&hl=en&oi=ao She completed her PhD training as an epidemiologist in 2018 with Cochrane Australia at Monash University and recently completed a postdoctoral research fellowship with the Therapeutics Initiative (Cochrane Hypertension Group) at the University of British Columbia. She is a member of the several methods groups at Cochrane\, academic board advisor for Researchsquare.com\, and academic editor for PeerJ. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-the-development-of-a-risk-of-bias-tool-for-network-meta-analysis-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T130000
DTSTAMP:20260404T183519
CREATED:20210315T193355Z
LAST-MODIFIED:20210315T193355Z
UID:27976-1617192000-1617195600@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: The Development of a Risk of Bias Tool for Network Meta-Analysis
DESCRIPTION:The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nTITLE: The development of a risk of bias tool for network meta-analysis \nSPEAKER: Dr. Carole Lunny\, Postdoctoral Research Fellow\, Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, ON. \n\nAbout the topic: In this presentation\, Dr. Lunny will describe tools that are currently used to assess the quality and risk of bias in systematic reviews with or without meta-analysis\, and justify why a new risk of bias tool for NMAs is needed. She will also describe the way to choose a quality assessment tool based on rigorous methodology and describe proposed methods for the development of a risk of bias tool for NMAs. Scroll down to read the abstract for this presentation. \nAbout the speaker: Dr. Carole Lunny is a postdoc research methodologist with the Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, and a Methodology Editor with the Cochrane Hypertension Review Group\, the Therapeutics Initiative at the University of British Columbia. She specializes in methods for research synthesis and critical appraisal of systematic reviews with pairwise and network meta-analysis\, overviews of reviews\, randomised controlled trials\, and observational studies (cohort\, case control). Her current research focuses on the development of a risk of bias tool for network meta-analyses\, methods issues in clinical practice guidelines and ‘overviews of reviews’. Her list of publications can be found at: https://scholar.google.com/citations?user=YaJAbZsAAAAJ&hl=en&oi=ao She completed her PhD training as an epidemiologist in 2018 with Cochrane Australia at Monash University and recently completed a postdoctoral research fellowship with the Therapeutics Initiative (Cochrane Hypertension Group) at the University of British Columbia. She is a member of the several methods groups at Cochrane\, academic board advisor for Researchsquare.com\, and academic editor for PeerJ. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-the-development-of-a-risk-of-bias-tool-for-network-meta-analysis-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T130000
DTSTAMP:20260404T183519
CREATED:20210315T193355Z
LAST-MODIFIED:20210315T193355Z
UID:31061-1617192000-1617195600@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: The Development of a Risk of Bias Tool for Network Meta-Analysis
DESCRIPTION:The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nTITLE: The development of a risk of bias tool for network meta-analysis \nSPEAKER: Dr. Carole Lunny\, Postdoctoral Research Fellow\, Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, ON. \n\nAbout the topic: In this presentation\, Dr. Lunny will describe tools that are currently used to assess the quality and risk of bias in systematic reviews with or without meta-analysis\, and justify why a new risk of bias tool for NMAs is needed. She will also describe the way to choose a quality assessment tool based on rigorous methodology and describe proposed methods for the development of a risk of bias tool for NMAs. Scroll down to read the abstract for this presentation. \nAbout the speaker: Dr. Carole Lunny is a postdoc research methodologist with the Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, and a Methodology Editor with the Cochrane Hypertension Review Group\, the Therapeutics Initiative at the University of British Columbia. She specializes in methods for research synthesis and critical appraisal of systematic reviews with pairwise and network meta-analysis\, overviews of reviews\, randomised controlled trials\, and observational studies (cohort\, case control). Her current research focuses on the development of a risk of bias tool for network meta-analyses\, methods issues in clinical practice guidelines and ‘overviews of reviews’. Her list of publications can be found at: https://scholar.google.com/citations?user=YaJAbZsAAAAJ&hl=en&oi=ao She completed her PhD training as an epidemiologist in 2018 with Cochrane Australia at Monash University and recently completed a postdoctoral research fellowship with the Therapeutics Initiative (Cochrane Hypertension Group) at the University of British Columbia. She is a member of the several methods groups at Cochrane\, academic board advisor for Researchsquare.com\, and academic editor for PeerJ. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-the-development-of-a-risk-of-bias-tool-for-network-meta-analysis-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T130000
DTSTAMP:20260404T183519
CREATED:20210315T193355Z
LAST-MODIFIED:20210315T193355Z
UID:32521-1617192000-1617195600@scienceinvancouver.com
SUMMARY:TI Methods Speaker Series: The Development of a Risk of Bias Tool for Network Meta-Analysis
DESCRIPTION:The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month and used to take place in Rudy North Lecture Theatre (CBH 101) in the Centre for Brain Health\, UBC Point Grey Campus. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online.  \n\nTITLE: The development of a risk of bias tool for network meta-analysis \nSPEAKER: Dr. Carole Lunny\, Postdoctoral Research Fellow\, Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, ON. \n\nAbout the topic: In this presentation\, Dr. Lunny will describe tools that are currently used to assess the quality and risk of bias in systematic reviews with or without meta-analysis\, and justify why a new risk of bias tool for NMAs is needed. She will also describe the way to choose a quality assessment tool based on rigorous methodology and describe proposed methods for the development of a risk of bias tool for NMAs. Scroll down to read the abstract for this presentation. \nAbout the speaker: Dr. Carole Lunny is a postdoc research methodologist with the Knowledge Synthesis Team\, at Unity Health\, University of Toronto\, and a Methodology Editor with the Cochrane Hypertension Review Group\, the Therapeutics Initiative at the University of British Columbia. She specializes in methods for research synthesis and critical appraisal of systematic reviews with pairwise and network meta-analysis\, overviews of reviews\, randomised controlled trials\, and observational studies (cohort\, case control). Her current research focuses on the development of a risk of bias tool for network meta-analyses\, methods issues in clinical practice guidelines and ‘overviews of reviews’. Her list of publications can be found at: https://scholar.google.com/citations?user=YaJAbZsAAAAJ&hl=en&oi=ao She completed her PhD training as an epidemiologist in 2018 with Cochrane Australia at Monash University and recently completed a postdoctoral research fellowship with the Therapeutics Initiative (Cochrane Hypertension Group) at the University of British Columbia. She is a member of the several methods groups at Cochrane\, academic board advisor for Researchsquare.com\, and academic editor for PeerJ. \nAbout the TI Methods Speaker Series: The TI Methods Speaker Series are offered free of charge and everyone is welcome. The event is held at noon on the last Wednesday of each month. During the COVID-19 pandemic\, while physical distancing measures are in effect\, the TI Methods Speaker Series are offered via videoconference. The presentations are recorded and the video recordings are posted online. Click here to view the scheduled topics for 2021 and click here to view a list of TI Methods Speaker Series talks offered in 2020.
URL:https://scienceinvancouver.com/event/ti-methods-speaker-series-the-development-of-a-risk-of-bias-tool-for-network-meta-analysis-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T133000
DTSTAMP:20260404T183519
CREATED:20210302T161549Z
LAST-MODIFIED:20210316T171417Z
UID:15247-1617192000-1617197400@scienceinvancouver.com
SUMMARY:UBC Three-Minute Thesis Competition 2021
DESCRIPTION:Graduate students spend years mastering a subject. #UBC3MT asks them to present their research in just three minutes. Join us on March 31 for the 2021 finals to learn about their fascinating research.
URL:https://scienceinvancouver.com/event/ubc-three-minute-thesis-competition-2021/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/3MT_final_purple.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T133000
DTSTAMP:20260404T183519
CREATED:20210302T161549Z
LAST-MODIFIED:20210302T161549Z
UID:26350-1617192000-1617197400@scienceinvancouver.com
SUMMARY:UBC Three-Minute Thesis Competition 2021
DESCRIPTION:Graduate students spend years mastering a subject. #UBC3MT asks them to present their research in just three minutes. Join us on March 31 for the 2021 finals to learn about their fascinating research.
URL:https://scienceinvancouver.com/event/ubc-three-minute-thesis-competition-2021-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/3MT_final_purple.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T133000
DTSTAMP:20260404T183519
CREATED:20210302T161549Z
LAST-MODIFIED:20210302T161549Z
UID:27965-1617192000-1617197400@scienceinvancouver.com
SUMMARY:UBC Three-Minute Thesis Competition 2021
DESCRIPTION:Graduate students spend years mastering a subject. #UBC3MT asks them to present their research in just three minutes. Join us on March 31 for the 2021 finals to learn about their fascinating research.
URL:https://scienceinvancouver.com/event/ubc-three-minute-thesis-competition-2021-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/3MT_final_purple.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T133000
DTSTAMP:20260404T183519
CREATED:20210302T161549Z
LAST-MODIFIED:20210302T161549Z
UID:31048-1617192000-1617197400@scienceinvancouver.com
SUMMARY:UBC Three-Minute Thesis Competition 2021
DESCRIPTION:Graduate students spend years mastering a subject. #UBC3MT asks them to present their research in just three minutes. Join us on March 31 for the 2021 finals to learn about their fascinating research.
URL:https://scienceinvancouver.com/event/ubc-three-minute-thesis-competition-2021-4/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/3MT_final_purple.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210331T120000
DTEND;TZID=America/Vancouver:20210331T133000
DTSTAMP:20260404T183519
CREATED:20210302T161549Z
LAST-MODIFIED:20210302T161549Z
UID:32508-1617192000-1617197400@scienceinvancouver.com
SUMMARY:UBC Three-Minute Thesis Competition 2021
DESCRIPTION:Graduate students spend years mastering a subject. #UBC3MT asks them to present their research in just three minutes. Join us on March 31 for the 2021 finals to learn about their fascinating research.
URL:https://scienceinvancouver.com/event/ubc-three-minute-thesis-competition-2021-5/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/3MT_final_purple.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210401T150000
DTEND;TZID=America/Vancouver:20210401T163000
DTSTAMP:20260404T183519
CREATED:20210315T182524Z
LAST-MODIFIED:20210315T182524Z
UID:15575-1617289200-1617294600@scienceinvancouver.com
SUMMARY:From Lab to Life: Translation of Regenerative Medicine Therapies and Technologies
DESCRIPTION:Organized by UBC Faculty of Medicine and Vancouver Coastal Health Research Institute\, Discovery to Commercialization is a series of education and networking events that aim to improve awareness and knowledge of the commercialization process and provide opportunities to foster new relationships within the life sciences community. \nDiscovery to Commercialization brings together university faculty members\, graduate students and postdoctoral fellows\, health care leaders\, clinicians\, entrepreneurs\, and commercialization stakeholders who are passionate about taking innovative research discoveries through the commercialization process. \n\nJoin us in a series of virtual sessions to hear from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. \nSession Details: \nFrom Lab to Life: Translation of Regenerative Medicine Therapies and Technologies \nGain insights and virtually interact with our featured academic and industry leaders to hear about their experience in translating regenerative medicine therapies and technologies \nSpeakers: \nDr. Gregory Block\, Senior Vice President\, Contract Development\, Notch Therapeutics \nDr. Timothy Kieffer\, Professor\, Cellular and Physiological Sciences and Surgery\, UBC \nDr. Megan Levings\, Professor\, Surgery and School of Biomedical Engineering\, UBC \nDr. Fabio Rossi\, Professor and Director\, Biomedical Research Centre\, UBC \nDr. Sam Wadsworth\, Chief Scientific Officer\, Aspect Biosystems \n 
URL:https://scienceinvancouver.com/event/from-lab-to-life-translation-of-regenerative-medicine-therapies-and-technologies/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Discovery-to-Commercialization.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210401T150000
DTEND;TZID=America/Vancouver:20210401T163000
DTSTAMP:20260404T183519
CREATED:20210315T182524Z
LAST-MODIFIED:20210315T182524Z
UID:26358-1617289200-1617294600@scienceinvancouver.com
SUMMARY:From Lab to Life: Translation of Regenerative Medicine Therapies and Technologies
DESCRIPTION:Organized by UBC Faculty of Medicine and Vancouver Coastal Health Research Institute\, Discovery to Commercialization is a series of education and networking events that aim to improve awareness and knowledge of the commercialization process and provide opportunities to foster new relationships within the life sciences community. \nDiscovery to Commercialization brings together university faculty members\, graduate students and postdoctoral fellows\, health care leaders\, clinicians\, entrepreneurs\, and commercialization stakeholders who are passionate about taking innovative research discoveries through the commercialization process. \n\nJoin us in a series of virtual sessions to hear from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. \nSession Details: \nFrom Lab to Life: Translation of Regenerative Medicine Therapies and Technologies \nGain insights and virtually interact with our featured academic and industry leaders to hear about their experience in translating regenerative medicine therapies and technologies \nSpeakers: \nDr. Gregory Block\, Senior Vice President\, Contract Development\, Notch Therapeutics \nDr. Timothy Kieffer\, Professor\, Cellular and Physiological Sciences and Surgery\, UBC \nDr. Megan Levings\, Professor\, Surgery and School of Biomedical Engineering\, UBC \nDr. Fabio Rossi\, Professor and Director\, Biomedical Research Centre\, UBC \nDr. Sam Wadsworth\, Chief Scientific Officer\, Aspect Biosystems \n 
URL:https://scienceinvancouver.com/event/from-lab-to-life-translation-of-regenerative-medicine-therapies-and-technologies-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Discovery-to-Commercialization.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210401T150000
DTEND;TZID=America/Vancouver:20210401T163000
DTSTAMP:20260404T183519
CREATED:20210315T182524Z
LAST-MODIFIED:20210315T182524Z
UID:27972-1617289200-1617294600@scienceinvancouver.com
SUMMARY:From Lab to Life: Translation of Regenerative Medicine Therapies and Technologies
DESCRIPTION:Organized by UBC Faculty of Medicine and Vancouver Coastal Health Research Institute\, Discovery to Commercialization is a series of education and networking events that aim to improve awareness and knowledge of the commercialization process and provide opportunities to foster new relationships within the life sciences community. \nDiscovery to Commercialization brings together university faculty members\, graduate students and postdoctoral fellows\, health care leaders\, clinicians\, entrepreneurs\, and commercialization stakeholders who are passionate about taking innovative research discoveries through the commercialization process. \n\nJoin us in a series of virtual sessions to hear from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. \nSession Details: \nFrom Lab to Life: Translation of Regenerative Medicine Therapies and Technologies \nGain insights and virtually interact with our featured academic and industry leaders to hear about their experience in translating regenerative medicine therapies and technologies \nSpeakers: \nDr. Gregory Block\, Senior Vice President\, Contract Development\, Notch Therapeutics \nDr. Timothy Kieffer\, Professor\, Cellular and Physiological Sciences and Surgery\, UBC \nDr. Megan Levings\, Professor\, Surgery and School of Biomedical Engineering\, UBC \nDr. Fabio Rossi\, Professor and Director\, Biomedical Research Centre\, UBC \nDr. Sam Wadsworth\, Chief Scientific Officer\, Aspect Biosystems \n 
URL:https://scienceinvancouver.com/event/from-lab-to-life-translation-of-regenerative-medicine-therapies-and-technologies-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Discovery-to-Commercialization.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210401T150000
DTEND;TZID=America/Vancouver:20210401T163000
DTSTAMP:20260404T183519
CREATED:20210315T182524Z
LAST-MODIFIED:20210315T182524Z
UID:31057-1617289200-1617294600@scienceinvancouver.com
SUMMARY:From Lab to Life: Translation of Regenerative Medicine Therapies and Technologies
DESCRIPTION:Organized by UBC Faculty of Medicine and Vancouver Coastal Health Research Institute\, Discovery to Commercialization is a series of education and networking events that aim to improve awareness and knowledge of the commercialization process and provide opportunities to foster new relationships within the life sciences community. \nDiscovery to Commercialization brings together university faculty members\, graduate students and postdoctoral fellows\, health care leaders\, clinicians\, entrepreneurs\, and commercialization stakeholders who are passionate about taking innovative research discoveries through the commercialization process. \n\nJoin us in a series of virtual sessions to hear from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. \nSession Details: \nFrom Lab to Life: Translation of Regenerative Medicine Therapies and Technologies \nGain insights and virtually interact with our featured academic and industry leaders to hear about their experience in translating regenerative medicine therapies and technologies \nSpeakers: \nDr. Gregory Block\, Senior Vice President\, Contract Development\, Notch Therapeutics \nDr. Timothy Kieffer\, Professor\, Cellular and Physiological Sciences and Surgery\, UBC \nDr. Megan Levings\, Professor\, Surgery and School of Biomedical Engineering\, UBC \nDr. Fabio Rossi\, Professor and Director\, Biomedical Research Centre\, UBC \nDr. Sam Wadsworth\, Chief Scientific Officer\, Aspect Biosystems \n 
URL:https://scienceinvancouver.com/event/from-lab-to-life-translation-of-regenerative-medicine-therapies-and-technologies-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Discovery-to-Commercialization.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210401T150000
DTEND;TZID=America/Vancouver:20210401T163000
DTSTAMP:20260404T183519
CREATED:20210315T182524Z
LAST-MODIFIED:20210315T182524Z
UID:32517-1617289200-1617294600@scienceinvancouver.com
SUMMARY:From Lab to Life: Translation of Regenerative Medicine Therapies and Technologies
DESCRIPTION:Organized by UBC Faculty of Medicine and Vancouver Coastal Health Research Institute\, Discovery to Commercialization is a series of education and networking events that aim to improve awareness and knowledge of the commercialization process and provide opportunities to foster new relationships within the life sciences community. \nDiscovery to Commercialization brings together university faculty members\, graduate students and postdoctoral fellows\, health care leaders\, clinicians\, entrepreneurs\, and commercialization stakeholders who are passionate about taking innovative research discoveries through the commercialization process. \n\nJoin us in a series of virtual sessions to hear from experienced faculty and industry partners\, and leave educated and inspired about the local companies in our community. \nSession Details: \nFrom Lab to Life: Translation of Regenerative Medicine Therapies and Technologies \nGain insights and virtually interact with our featured academic and industry leaders to hear about their experience in translating regenerative medicine therapies and technologies \nSpeakers: \nDr. Gregory Block\, Senior Vice President\, Contract Development\, Notch Therapeutics \nDr. Timothy Kieffer\, Professor\, Cellular and Physiological Sciences and Surgery\, UBC \nDr. Megan Levings\, Professor\, Surgery and School of Biomedical Engineering\, UBC \nDr. Fabio Rossi\, Professor and Director\, Biomedical Research Centre\, UBC \nDr. Sam Wadsworth\, Chief Scientific Officer\, Aspect Biosystems \n 
URL:https://scienceinvancouver.com/event/from-lab-to-life-translation-of-regenerative-medicine-therapies-and-technologies-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/03/Discovery-to-Commercialization.png
END:VEVENT
END:VCALENDAR